4-Week Study of Efficacy, Safety and PK of Albuterol-HFA Versus Proventil-HFA in Pediatric Asthma
Status:
Terminated
Trial end date:
2008-12-01
Target enrollment:
Participant gender:
Summary
This 4-week clinical study evaluates the efficacy and safety of Albuterol Sulfate HFA
Inhalation Aerosol in comparison with the Active Control, Proventil-HFA (3M Pharmaceuticals,
Inc) in pediatric patients (4-11 years old) with mild-to-moderate asthma. In addition,
pharmacokinetic profile in this population will be evaluated using a population PK approach
with sparse blood samples.